BR112012011598A2 - polipeptídeos de haemophilus parasuis e métodos de uso - Google Patents

polipeptídeos de haemophilus parasuis e métodos de uso

Info

Publication number
BR112012011598A2
BR112012011598A2 BR112012011598A BR112012011598A BR112012011598A2 BR 112012011598 A2 BR112012011598 A2 BR 112012011598A2 BR 112012011598 A BR112012011598 A BR 112012011598A BR 112012011598 A BR112012011598 A BR 112012011598A BR 112012011598 A2 BR112012011598 A2 BR 112012011598A2
Authority
BR
Brazil
Prior art keywords
polypeptides
methods
haemophilus parasuis
present
polypeptide
Prior art date
Application number
BR112012011598A
Other languages
English (en)
Inventor
Simone Oliveira
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of BR112012011598A2 publication Critical patent/BR112012011598A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Abstract

polipeptídeos haemophilus parasuis e métodos de uso. a presente invenção proporciona polipeptídeos isolados tendo atividade permease oligopeptídeo e uma sequência de aminoácidos que tem pelo menos 80% de identidade com um polipeptídeo hemophilus parasuis oppa. é também proporcionado pela presente invenção são polinucleotídeos isolados que codificam os polipeptídeos aqui descritos, e de anticorpo que se liga especificamente um polipeptídeo aqui descrito. a presente invenção proporciona ainda micróbios geneticamente modificados, tais como estirpes atenuadas de haemophilus parasuis e outros micróbios que expressam polipeptídeos aqui descrito. também estão incluídos os métodos para usar os polipeptídeos, polinucleotídeos, anticorpos, e os micróbios geneticamente modificados.
BR112012011598A 2009-11-04 2010-11-04 polipeptídeos de haemophilus parasuis e métodos de uso BR112012011598A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25792109P 2009-11-04 2009-11-04
US31446810P 2010-03-16 2010-03-16
PCT/US2010/055425 WO2011056954A2 (en) 2009-11-04 2010-11-04 Haemophilus parasuis polypeptides and methods of use

Publications (1)

Publication Number Publication Date
BR112012011598A2 true BR112012011598A2 (pt) 2016-06-28

Family

ID=43902974

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012011598A BR112012011598A2 (pt) 2009-11-04 2010-11-04 polipeptídeos de haemophilus parasuis e métodos de uso

Country Status (5)

Country Link
US (1) US8911743B2 (pt)
EP (1) EP2496254A2 (pt)
BR (1) BR112012011598A2 (pt)
CA (1) CA2779515A1 (pt)
WO (1) WO2011056954A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404253B2 (en) * 2006-12-28 2013-03-26 Newport Laboratories, Inc. Modified live (JMSO strain) Haemophilus parasuis vaccine
CN101981052B (zh) * 2008-03-28 2014-11-26 诺华股份有限公司 组合物、方法及试剂盒
CN103364548B (zh) * 2013-07-25 2015-03-18 江苏省农业科学院 一种副猪嗜血杆菌间接血凝检测试剂
CN104251905B (zh) * 2014-09-01 2016-05-18 中国农业科学院兰州兽医研究所 一种副猪嗜血杆菌试纸条及其制备方法
US10393525B2 (en) * 2015-05-22 2019-08-27 Georgia Tech Research Corporation Micro-hemispherical resonators and methods of making the same
CN105524857A (zh) * 2015-09-17 2016-04-27 龙岩学院 一种副猪嗜血杆菌菌株
CN110327460A (zh) * 2019-06-05 2019-10-15 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猪链球菌病-副猪嗜血杆菌病二联亚单位疫苗及制备方法
CN110376388B (zh) * 2019-08-16 2021-10-19 南京农业大学 一种副猪嗜血杆菌抗体检测方法及其试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782137A (en) 1984-01-24 1988-11-01 Immunex Corporation Synthesis of protein with an identification peptide, and hybrid polypeptide incorporating same
US4703004A (en) 1984-01-24 1987-10-27 Immunex Corporation Synthesis of protein with an identification peptide
US5594115A (en) 1990-04-09 1997-01-14 Pharmacia & Upjohn Company Process of purifying recombinant proteins and compounds useful in such process
US5935824A (en) 1996-01-31 1999-08-10 Technologene, Inc. Protein expression system
US8404253B2 (en) * 2006-12-28 2013-03-26 Newport Laboratories, Inc. Modified live (JMSO strain) Haemophilus parasuis vaccine

Also Published As

Publication number Publication date
US8911743B2 (en) 2014-12-16
US20130129682A1 (en) 2013-05-23
CA2779515A1 (en) 2011-05-12
EP2496254A2 (en) 2012-09-12
WO2011056954A2 (en) 2011-05-12
WO2011056954A3 (en) 2011-10-20
WO2011056954A8 (en) 2011-08-25

Similar Documents

Publication Publication Date Title
BR112012011598A2 (pt) polipeptídeos de haemophilus parasuis e métodos de uso
BR112018074325A2 (pt) anticorpo para ligação a receptor de interleucina 4
AU2017204797B2 (en) Antibodies with modified isoelectric points
MX2020004578A (es) Composiciones de casz y metodos de uso.
PE20191551A1 (es) Polipeptidos de union al receptor de transferrina disenados
BR122021020829B8 (pt) Proteína de ligação ao fator h de ocorrência não natural (fhbp), composição, e célula hospedeira de neisseria meningitidis geneticamente modificada
MX2014005108A (es) Constructos de polipeptidos y sus usos.
CL2008002861A1 (es) Polipeptido aislado de m. ruminantium; vector, molecula conjugada y celula huesped que comprenden dicho polipeptido; anticuerpo o fragmento que se une al polipeptido; composicion farmaceutica que comprende la molecula conjugada; metodo para dirigir una celula metanogena para identificacion, aislamiento o inhibicion.
SG10201807877TA (en) Hybrid immunoglobulin containing non-peptidyl linkage
MX2015014608A (es) Novedosas moleculas de union biespecifica con actividad antitumoral.
NZ591855A (en) Novel immunotherapy against several tumors including neuronal and brain tumors
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
BR112013010855A2 (pt) luciferases derivadas de oplophorus, novos substratos de coelenterazina e métodos de uso
EP2532366A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
BR112013008407A2 (pt) antígenos de clostridium difficile
UA98983C2 (uk) Антитіло проти гепсидину та його застосування
BR112018003594A2 (pt) cadeia pesada de imunoglobulina recombinante, anticorpos, método de produção de conjugado e conjugados
MY187827A (en) New polypeptide having affinity to pd-l1
MX2017000083A (es) Compuestos de platino, composiciones y usos de estos.
WO2015130846A3 (en) Compositions and methods for the site-specific modification of polypeptides
BR112014024282A2 (pt) anticorpos ligantes ao receptor b1 da bradicinina
BRPI0607323B8 (pt) composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
MX2015003150A (es) Anticuerpos específicos de polipeptido amiloide de islote humano (hiapp) y sus usos.
AU2011353197A8 (en) A cross linking polypeptide comprising an hexameric single chain antibody binding MHC-MAGE complex that induces apoptosis
BR112016014913A8 (pt) anticorpo, ou um fragmento de ligação ao antígeno do mesmo, conjugado, ácido nucléico, vetor, célula hospedeira, composição farmacêutica, método de preparo de uma cadeia leve de um anticorpo ou fragmento de ligação ao antígeno e método de preparo de um conjugado

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]